文献速递临床试验与 GCP

急性股骨骨折固定试验(TrAFFix):随机对照可行性试验研究方案

Trial of Acute Femoral Fracture Fixation (TrAFFix): study protocol for a randomised controlled feasibility trial.
PubMed 文献 · Trials · 2017-11-14

TrAFFix是一项随机平行组可行性研究,旨在为比较髓内钉与锁定钢板治疗股骨远端骨折的后续确定性临床试验提供设计依据。研究对象为50岁及以上、股骨远端两个Müller方格内骨折的患者,随机分配至髓内钉或远端锁定钢板固定组,在基线、6周和4个月收集EuroQol 5 Dimensions、Dementia Quality of Life和Disability Rating Index测量数据。主要评估招募率和主要结局指标的完成率,并结合过程评估输出决定可行性。

要点

  • 研究评估50岁及以上股骨远端骨折患者髓内钉与锁定钢板的可行性。
  • 在7个中心共52个中心月内评估招募率,预计招募10个月后完成。
  • 4个月时量化两组健康相关生活质量的观察差异并推断。

核心结论

  • 该研究为可行性研究方案,将结合参与者招募率、数据完成比例估计与过程评估输出,就是否可行做出最终决定。

研究设计与样本

  • 随机平行组可行性研究,比较髓内钉与锁定钢板治疗股骨远端骨折。
  • 计划在7个参与中心共52个中心月内评估招募率,预计招募10个月后完成。
  • 纳入标准为50岁及以上、股骨远端两个Müller方格内骨折的患者。

主要发现

  • 可行性阶段评估招募率和主要结局指标的完成率。
  • 过程评估评估未来试验的可推广性和可能成功率。
  • 确定性试验阶段量化并推断4个月时髓内钉与钢板组间健康相关生活质量观察差异。

关键数值与推荐

  • 测量工具包括EuroQol 5 Dimensions、Dementia Quality of Life和Disability Rating Index,在基线、6周和4个月收集。
  • 研究获威尔士研究伦理委员会 favourable opinion(16/WA/0225),NHS批准由Health Research Authority给出(IRAS 206745),参与NHS信托提供当地批准。
  • 研究由National Institute for Health Research Health Technology Assessment资助(HTA 15/59/22)。
  • 试验注册于National Institute for Health Research Portfolio(CPMS ID: 32536)和ISRCTN registry(ISRCTN92089567),注册日期2016年5月26日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Distal femoral fractures are a source of considerable morbidity and best treatment is currently uncertain. The Trial of Acute Femoral Fracture Fixation (TrAFFix) is a randomised, parallel-group feasibility study designed to inform the design of a later, definitive clinical trial comparing intramedullary nails and locking plates for the treatment of distal femoral fractures. METHODS/DESIGN: Patients aged 50 years and older with a femoral fracture within the distal two Müller squares are potentially eligible for inclusion. Participants are randomly allocated to receive fixation with either an intramedullary nail or a distal locking plate. Measurements (EuroQol 5 Dimensions, Dementia Quality of Life, Disability Rating Index) are collected at baseline, 6 weeks and 4 months. The recruitment rate will be assessed across seven participating centres over a total of 52 centre-months which is expected after 10 months of recruitment. Objectives are - feasibility phase, to assess recruitment rate and completion rate of the primary outcome measure; process evaluation, to assess the generalisability and likely success of a future trial; definitive trial, quantify and draw inferences on observed differences in health-related quality of life at 4 months between the study intervention groups (nail versus plate). A favourable opinion was granted by the Wales Research Ethics Committee (16/WA/0225), study-wide NHS approval was given by the Health Research Authority (IRAS 206745), and participating NHS trusts provided local approvals. This study was funded by the National Institute for Health Research Health Technology Assessment (HTA 15/59/22). DISCUSSION: This is the protocol for a feasibility study conducted prior to any future definitive trial. The estimates of participant recruitment rate and proportion of data completion will be coupled with outputs from the process evaluation to make a final decision regarding feasibility TRIAL REGISTRATIONS: The study is registered with the National Institute for Health Research Portfolio (CPMS ID: 32536) and the ISRCTN registry ( ISRCTN92089567 ) on 26 May 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Griffin XL, Costa ML, Achten J, et al. Trial of Acute Femoral Fracture Fixation (TrAFFix): study protocol for a randomised controlled feasibility trial. Trials. 2017. PMID: 29137679. doi:10.1186/s13063-017-2265-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。